Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Safety and tolerability study in healthy volunteers
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| A | Experimental | bifeprunox 25 day |
|
| B | Experimental | bifeprunox 14 day |
|
| C | Experimental | bifeprunox 14 day |
|
| D | Experimental | bifeprunox 9 day |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| bifeprunox | Drug | oral tablet once daily |
|
| Measure | Description | Time Frame |
|---|---|---|
| Tolerability | 28 days |
| Measure | Description | Time Frame |
|---|---|---|
| Safety | 28 days |
Not provided
Inclusion criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Medical Monitor | Wyeth is now a wholly owned subsidiary of Pfizer | Study Director |
Not provided
Not provided
| ID | Term |
|---|---|
| C509981 | bifeprunox |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided